Edition:
United Kingdom

Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

1.37USD
4:10pm GMT
Change (% chg)

$-0.03 (-2.14%)
Prev Close
$1.40
Open
$1.40
Day's High
$1.40
Day's Low
$1.37
Volume
1,086
Avg. Vol
28,826
52-wk High
$3.88
52-wk Low
$1.32

Latest Key Developments (Source: Significant Developments)

Onconova Therapeutics files for mixed shelf offering of upto $84.5 mln
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Onconova Therapeutics Inc ::Onconova Therapeutics Inc files for mixed shelf offering of upto $84.5 million- SEC filing‍​.  Full Article

Onconova Therapeutics prices public offering
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Onconova Therapeutics Inc :Onconova Therapeutics announces pricing of public offering of common stock.Agreed to sell approximately 920,000 shares of its common stock for gross proceeds of approximately $1.38 million​.Each share of common stock is being sold at a price of $1.50 per share​.  Full Article

Onconova Therapeutics reports Q3 revenue $100,000
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Onconova Therapeutics Inc :Onconova Therapeutics, Inc. reports business highlights and third quarter 2017 financial results.Q3 revenue $100,000 versus $1.7 million.Q3 revenue view $152,000 -- Thomson Reuters I/B/E/S.Onconova Therapeutics Inc - Qtrly loss per share $0.71.  Full Article

Onconova Therapeutics announces plan of termination to reduce a number of positions
Tuesday, 30 Aug 2016 

Onconova Therapeutics : On August 30, communicated to certain employees its plan of termination to reduce a number of positions effective as of August 30 . Estimates net reduction to be about 6 employees, which represents about 21 percent of its workforce - SEC filing .As a result of workforce reduction, estimates will have annual net savings of about $1.4 million.  Full Article

Premkumar Reddy reports a stake of 5.8 pct in Onconova Therapeutics
Friday, 19 Aug 2016 

:Premkumar Reddy reports a stake of 5.8 pct in Onconova Therapeutics Inc as of July 29, 2016 - SEC Filing.  Full Article

Tyndall Capital reports 13.5 percent passive stake in Onconova
Thursday, 18 Aug 2016 

Onconova Therapeutics Inc :Tyndall Capital Partners LP reports 13.5 percent passive stake in Onconova Therapeutics Inc, as of July 29, 2016 - SEC filing.  Full Article

Onconova Therapeutics Q2 loss per share $1.96
Monday, 15 Aug 2016 

Onconova Therapeutics Inc : Onconova Therapeutics Inc reports recent business highlights and second quarter 2016 financial results . Qtrly loss per share $1.96 . Q2 revenue $2.2 million versus $100,000 .Initiated discussions with U.S. European regulatory authorities towards formal end-of-phase 2 meetings for oral rigosertib.  Full Article

Onconova Therapeutics Q1 revenue $1.5 mln vs $100,000
Wednesday, 11 May 2016 

Onconova Therapeutics Inc : Onconova Therapeutics, Inc. Reports recent business highlights and first quarter 2016 financial results .Q1 revenue $1.5 million versus $100,000.  Full Article

Onconova Therapeutics Inc announces registered direct offering
Wednesday, 6 Jan 2016 

Onconova Therapeutics Inc:Entered into a definitive agreement with a single institutional investor to receive gross proceeds of approximately $1.84 million.In connection with the offering, the Company will issue approximately 1.9 million registered shares of common stock at a purchase price of $0.95 per share in a registered direct offering.  Full Article

BRIEF-Onconova Therapeutics files for mixed shelf offering of upto $84.5 mln

* Onconova Therapeutics Inc files for mixed shelf offering of upto $84.5 million- SEC filing‍​ Source text: (http://bit.ly/2AiGwl1) Further company coverage: